Delivery Order SPE2DB22D1106-SPE2DB24FFLQ3
Award Date
9/9/24
Potential Completion Date
9/10/24
Potential Value
$5.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVANSE 20 MG CAPSULE 100S, a prescription medication, with a ceiling value of $1,346.26 and a completion date of May 15, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award, with ID SPE2DB22D1106|SPE2DB24FFET8, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,108.48 firm fixed-price delivery order is for the supply of 100 units of VYVANSE 70 MG CAPSULE, a prescription medication. The contract has an ultimate completion date of July 31, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen...
This federal contract award, with an ID of SPE2DB22D1106|SPE2DB25FDSD8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVANSE 50 MG CAPSULE 100S, a pharmaceutical product, with a ceiling value of $12,376.39 and a completion date of December 30, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it is not designated as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of VYVANSE 20 MG CAPSULE 100S. The contract has a ceiling value of $1,600.66 and a period of performance through April 29, 2024. It is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This...
This federal contract award, with ID SPE2DB20D1051|SPE2DB25FD5YH, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4566188939 VYVANSE 30 MG CAPSULE 100S, with a ceiling value of $2,196.04. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of October 24, 2024. The contract was awarded on October 23, 2024 and does not have a set-aside designation....
This federal contract award, valued at $3,666.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, covers the supply of VYVANSE 50 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of November 14, 2024 and is a Firm Fixed Price arrangement....
The federal contract award SPE2DB24D1205/SPE2DB24FCULM was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VYVANSE 20 MG CAPSULE 100S. The contract has a ceiling value of $3,017.00 and is a Firm Fixed Price Delivery Order with a completion date of September 9, 2024. Amerisourcebergen has been awarded this contract under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...
This federal contract award, valued at $3,148.98, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVANSE 50 MG CAPSULE 100S, a prescription medication, with a completion date of October 30, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award with ID SPE2DB22D3016|SPE2DB25FAFK5 was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,975.08 firm fixed price delivery order is for the supply of 4,566,626,532 units of the medication VYVANSE 30 MG CAPSULE 100S. The contract has a completion date of December 6, 2024 and was awarded on December 5, 2024. This award is a delivery order under...
This federal contract award from the Defense Logistics Agency (DLA) is for the procurement of VYVANSE 50 MG CAPSULE 100S, a pharmaceutical product. The contract has a ceiling value of $1,783.60 and was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of March 28, 2025. The contract is not designated with...